Comparison

Thalidomide-NH-PEG2-C2-NH-Boc European Partner

Item no. HY-130853-100mg
Manufacturer MedChem Express
CASRN 2097509-40-3
Amount 100 mg
Quantity options 100 mg 10mM*1 mL 250 mg
Category
Type Inhibitors
Specific against other
Purity 98.37
Formula C24H32N4O8
Citations [1]David Remillard, et al. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.2017 May 15;56(21):5738-5743.
Smiles O=C(OC(C)(C)C)NCCOCCOCCNC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 2097509-40-3
Similar products 2097509-40-3
Available
Product Description
Thalidomide-NH-PEG2-C2-NH-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a PEG linker used for dBRD9 (compound 6) synthesis. dBRD9 is a selective BRD9 probe PROTAC degrader for the study of BAF complex biology[1].
StorageTemperature
-20°C (Powder, stored under nitrogen)
Shipping
Blue Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
504.53
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : ≥ 100 mg/mL
Target
Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
Manufacturers Target
Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
Isoform
Cereblon
Manufacturers Pathway
Apoptosis; Autophagy; PROTAC
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close